Cue Biopharma to Host Business Update Call and Webcast
CAMBRIDGE, Mass., Nov. 14, 2018 (GLOBE NEWSWIRE) — Cue Biopharma, Inc., (NASDAQ: CUE) an innovative immunotherapy company developing a novel, […]
CAMBRIDGE, Mass., Nov. 14, 2018 (GLOBE NEWSWIRE) — Cue Biopharma, Inc., (NASDAQ: CUE) an innovative immunotherapy company developing a novel, […]
RESEARCH TRIANGLE PARK, N.C., Nov. 14, 2018 (GLOBE NEWSWIRE) — Liquidia Technologies, Inc. (Nasdaq:LQDA) (“Liquidia”), a late-stage clinical biopharmaceutical company […]
Lays out key upcoming milestones for the next 12 months ELMSFORD, N.Y., Nov. 14, 2018 (GLOBE NEWSWIRE) — NanoVibronix, Inc, […]
CHARLOTTESVILLE, Va., Nov. 14, 2018 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW), a clinical-stage biopharmaceutical company focused on […]
EL SEGUNDO, Calif., Nov. 14, 2018 (GLOBE NEWSWIRE) — Landmark Infrastructure Partners LP (the “Partnership”) (NASDAQ: LMRK) announced today the […]
OneSpan’s Mobile Security Suite provides frictionless, mobile authentication using biometrics and risk assessment tools to reduce fraud CHICAGO, Nov. 14, […]
TORONTO, Nov. 14, 2018 (GLOBE NEWSWIRE) — Spectral Medical Inc., (TSX: EDT), a Phase III company developing the first treatment […]
Reports over $52 million of cash-on-hand with Company now fully funded beyond completion of the TRILOGY Phase 3 studies Both […]
TORONTO, Nov. 14, 2018 (GLOBE NEWSWIRE) — Canntab Therapeutics Limited (CSE: PILL, FSE: TBF1) (“Canntab” or the “Company”) is a […]
LONGUEUIL, Québec, Nov. 14, 2018 (GLOBE NEWSWIRE) — Stornoway Diamond Corporation (TSX-SWY; the “Corporation” or “Stornoway”) announces that, effective January […]